Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Core Insights - Dexcom has introduced an artificial intelligence feature for its Stelo continuous glucose monitor, providing users with personalized insights on how meals, sleep, and activity affect their glucose levels, marking the first use of a new generative AI platform developed in collaboration with Google Cloud [1][3]. Product Overview - Stelo is an over-the-counter continuous glucose monitor (CGM) that measures real-time blood sugar levels and is designed for adults who do not take insulin. It was launched in August and aims to enhance user engagement and personalization as Dexcom seeks to enter a new market [2]. User Feedback and AI Integration - The primary feedback from users is a desire for more insights from the data generated by the device. Dexcom is leveraging Google's Gemini models and Vertex AI platform to create applications that synthesize various data types, which is particularly challenging in healthcare [3]. Future Developments - Dexcom is considering the application of its generative AI platform across other CGM products, although it is proceeding cautiously due to the critical nature of these devices in preventing medical emergencies [4]. The company aims to transition from weekly reports to real-time feedback and predictive indicators for potential health issues [6]. AI Report Features - The AI-generated reports will be more personalized compared to the existing standard weekly reports, providing users with tailored tips and educational materials based on their activity levels and glucose readings [5]. However, these reports do not provide medical advice, and the development is guided by an AI framework from the U.S. Food and Drug Administration [6]. Rollout Information - The updated weekly report feature began rolling out to Stelo users this week, enhancing the overall user experience [8].